Keymed Biosciences IncKeymed Biosciences Inc - ESG Rating & Company Profile powered by AI

Industry Group:Biotechnology & Medical Research

This report of Keymed Biosciences Inc is assembled by All Street Sevva using proprietary NLP. This assessment of Keymed Biosciences Inc uses data points from across the internet as well as from public disclosures by Keymed Biosciences Inc. The webpage includes a questions and answers table on Keymed Biosciences Inc.

Keymed Biosciences Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 6.7, social score of 5.7 and governance score of 2.7.

SDG Transparency Score for Keymed Biosciences Inc 
Low
0 - 3

5.0

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Keymed Biosciences Inc 
6.7

Environmental

5.7

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Analytik Jena AG
8.0
High
1Amniotics AB (publ)
8.0
High
60Aethlon Medical Inc
5.2
High
62HBM Healthcare Investments AG
5.1
High
63Keymed Biosciences Inc
5.0
High
63Nightingale Health Oyj
5.0
High
65AVRA Medical Robotics Inc
4.9
High
.........
182Wesana Health Holdings Inc
0.0
Low
182rEVO Biologics Inc
0.0
Low
.........
View the full peer group of 404 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Keymed Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Keymed Biosciences Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Keymed Biosciences Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Keymed Biosciences Inc offer flexible work?

LockedSign up for free to unlock

Does Keymed Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Keymed Biosciences Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Keymed Biosciences Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose water use targets?

LockedSign up for free to unlock

Does Keymed Biosciences Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Keymed Biosciences Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Keymed Biosciences Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Keymed Biosciences Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Keymed Biosciences Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Keymed Biosciences Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Keymed Biosciences Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose its waste policy?

LockedSign up for free to unlock

Does Keymed Biosciences Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose energy use targets?

LockedSign up for free to unlock

Does Keymed Biosciences Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Keymed Biosciences Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Keymed Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.

Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company is also developing CM326, a monoclonal antibody targeting thymic stromal lymphopoietin to treat moderate-to severe AD, CRSwNP, asthma, and COPD. In addition, it develops CMG901 for the treatment of solid tumors, and gastric and gastroesophageal cancers; and CM313, a humanized monoclonal antibody to treat relapsed or refractory multiple myeloma, lymphoma and other hematological malignancies, and systemic lupus erythematosus. Further, the company is developing MIL95/CM312, a humanized monoclonal antibody targeting CD47; CM338, an antagonist antibody against mannose-binding lectinassociated serine protease-2; CM355 for the treatment of relapsed or refractory non-Hodgkin's lymphoma; CM336 to treat multiple myeloma; CM350 for the treatment of solid tumors; and CM369, an anti-CC chemokine receptor 8 monoclonal antibody. Keymed Biosciences Inc. was formerly known as 2Health Biosciences, Inc. The company was founded in 2016 and is headquartered in Chengdu, the People's Republic of China.

Sorry!

Failed to process!